By Melanie Fridl Ross
GAINESVILLE, Fla.---Researchers at Harvard and the University of Florida have identified a component of the human immune system that appears to prevent diabetes in a group of people considered highly likely to contract the disease.
The substance, a naturally occurring protein manufactured in large amounts in these individuals, is known as interleukin-4, or IL-4, researchers report in the Jan. 8 issue of Nature.
Insulin-dependent or "type 1" diabetes occurs when white blood cells vital to the body's defenses against infectious diseases launch a self-directed or "autoimmune" attack on insulin-producing beta cells in the pancreas. The insulin these beta cells produce regulates how the body uses and stores sugar and other food nutrients for energy. "The presence of this protein, IL-4, may suppress the arm of the immune system involved in the destruction of insulin-producing cells," said Mark Atkinson, director of UF's Center for Immunology and Transplantation. "By producing this large amount of IL-4, these people -- though they have an autoimmune event going on within their bodies -- seem to be prevented from developing diabetes."
Researchers studied identical twins, high-risk autoantibody-positive relatives and genetically matched controls. Autoantibodies signal the body's assault on pancreatic beta cells is under way, long before symptoms appear.
"More than 50 percent of these individuals should have gone on to develop autoimmune (type 1, insulin-dependent) diabetes during a five-year follow-up period," said Dr. Brian Wilson,who at the time of the study was a postdoctoral fellow in the department of molecular and cellular biology at Harvard University. Wilson collaborated with other Harvard researchers as well as the diabetes research group at UF. Wilson is now affiliated with the department of tumor virology at the Dana Farber Cancer Institute at Harvard Medical School.
"These people have these autoantibodies but don't ever go on to develop diabetes -- and it's always been a great mystery why," Atkinson said. "We think we've discovered a potential answer. The big question now is whether there is a way to take advantage of the situation so other autoantibody-positive people who don't make massive amounts of interleukin-4 don't develop the disease."
"If we looked across the board at twins who did not develop diabetes, all the T cells [white blood cells] of this regulatory ilk were making huge amounts of IL-4," Wilson said. "When we looked at the genetically identical twin who had type 1 diabetes, there was an absolute absence of the ability to make IL-4, and in fact, they made boatloads of an inflammatory agent."
More than 16 million Americans have diabetes. At least 150,000 die annually as a result of the disease and its complications, which include heart disease, stroke, blindness, kidney failure and poor circulation to the lower limbs.
UF and Harvard researchers are conducting a follow-up study of 69 families -- about 450 people -- that will further examine IL-4's protective role and whether its production is a genetic trait, Atkinson said.
Recent UF Health Science Center news releases also are available on the UF Health Science Center Communications home page. Point your browser to http://www.vpha.health.ufl.edu/hscc/index.html
For the UF Health Science Center topic/expert list, point your browser to http://www.health.ufl.edu/hscc/experts.html
The above post is reprinted from materials provided by University of Florida. Note: Content may be edited for style and length.
Cite This Page: